Pediatrics
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
The once-weekly injection offers a major convenience boost for children with Turner syndrome, reducing daily shots while maintaining comparable growth rates.
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
AbbVie Bets $2.5 Billion on DISCO’s Bispecific Platform to Expand Oncology Pipeline
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992

